This Month’s Features
This seven-step protocol is designed to mitigate risk factors and address existing periodontal inflammation.
Therapeutic approaches to managing hard tissue and soft tissue sensitivity.
Advances in radiography provide clinicians with more options than ever before for evaluating patients and planning implant treatment.
An examination and practical application of knowledge for clinicians who place and restore dental implants.
The key to successful implementation is a clinical understanding of the advantages and limitations of these modalities as they relate to each individual patient.
Because patients undergoing radiotherapy for head and neck cancer are susceptible to complications affecting tissues of the oral cavity, a comprehensive understanding of side effects is pivotal to successful case management.
The judicious use of opioids is only one facet of an effective — and responsible — pain management regimen.
The following strategies will help dental teams support the oral and systemic health of this growing patient population.
Knowledge and preparation will facilitate effective — and ongoing — oral health care for this patient group.
An article in the The New York Times about an epidemic of obesity in Malaysia reported that nearly half of the individuals in that country were overweight.
At a Glance
The evolution of bacteria resistant to most — or even all — antibiotics is a major global health threat.
Products and Services
Durable bioactive material offers excellent esthetics
A listing of featured products.
Fédération Dentaire Internationale, perhaps better known as the World Dental Federation, has launched new resources for oral health professionals that highlight the federation’s work to raise awareness of periodontal health as a priority area for global policy.
Adolescents between the ages of 12 to 17 who use e-cigarettes, smokeless tobacco or tobacco water pipes are more likely to move to conventional cigarettes within a year.
This year, Ultradent celebrates 40 years in the dental industry.
Patients who are undergoing radiotherapy for head and neck cancer are susceptible to numerous side effects that manifest in the oral cavity.
Photomedics, an oral health technology company based out of the Forsyth Institute in Boston, has developed the Photomedics BlueLight.
SDI North America has received registration approval from the federal Food and Drug Administration to market Riva Star in the United States as a “new generation” silver diamine fluoride (SDF) desensitizer.